NCT03499821已完成不适用
A Multicenter Clinical Evaluation of the Clinical Performance of a Phakic Intraocular Lens
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 41
- 试验地点
- 6
- 主要终点
- Number of Eyes With Monocular Uncorrected Near Visual Acuity of 20/40 or Better at 40 cm 6 Months After Implantation
研究概览
简要总结
This study will evaluate the clinical performance of a phakic intraocular lens (IOL) for the improvement of Uncorrected Near Visual Acuity (UCNVA) in subjects who require between +1.00 and +2.50 Reading Add.
详细描述
This is a prospective, open-labeled, multi-site evaluation of clinical performance of the STAAR EVO+ Visian™ Implantable Collamer® Lens (VICL) with Aspheric (EDOF) Optic [EDOF ICL] for the improvement of UCNVA in subjects who require between +1.00 and +2.50 Reading Add.
Approximately 48 subjects who meet all eligibility criteria will undergo EDOF ICL implantation in both eyes. All eyes will be followed for 6 months after surgery.
The first eye implanted with the study lens and the appropriate time for fellow eye implantation will be determined by the medical judgement of the Investigator. All eyes will be analyzed for safety and performance.
The primary performance endpoint is defined as achievement of monocular UCNVA of Snellen equivalent 20/40 or better at 40 cm at 6 months after implantation in equal to or greater than 75% of implanted eyes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 40 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Must be able to read, understand and provide written informed consent,
- •Willing and able to comply with all treatment and follow-up study related procedures,
- •40 - 60 years of age at time of surgery if require spherical lens powers from -0.50 D to -18.00 D,
- •35 - 45 years of age at time of surgery if require a spherical lens power from 0.0 D to +3.00 D,
- •Preoperative refraction fully correctable with available lens powers, with ≤ 0.75 D preoperative refractive and residual cylinder,
- •< 0.75 D spherical equivalent difference between cycloplegic and manifest refractions,
- •Stable correction (± 0.50 D) as determined by manifest refraction spherical equivalent (MRSE),
- •Best Corrected Distance Visual Acuity 20/20 or better in both eyes,
- •Requires +1.00 D to +2.50 D reading add,
- •Anterior chamber depth (ACD) ≥ 2.8 mm if require spherical lens powers from -0.50 D to -18.00 D,
- •ACD ≥ 3.0 mm if require spherical lens powers from 0.00 D to +3.00 D,
- •Anterior chamber angle ≥ Grade III,
- •Phakic in both eyes,
- •Current contact lens wearers need to demonstrate a stable refraction, (± 0.5 D), expressed as MRSE, on two consecutive examination dates with refractive stability determined by the following criteria:
- •contact lenses were not worn for at least 2 weeks (rigid and toric contact lenses) or 3 days (soft contact lenses) prior to the first refraction,
- •two refractions were performed at least 7 days apart.
排除标准
- •Participation in a clinical trial within 30 days prior to entry into this study and/or during the period of study participation,
- •Previous intraocular or corneal surgery in either eye, including refractive surgery,
- •Progressive sight threatening disease or other previous or current ocular conditions, other than myopia in either eye,
- •Low/abnormal corneal endothelial cell density,
- •Presence of active or history of chronic inflammation in either eye,
- •Clinically significant irregular astigmatism in either eye,
- •Serious, acute, chronic or systemic, non-ophthalmic disease or illness that would increase the operative risk, confound the outcome(s) of the study or which may preclude study completion,
- •Use of topical steroids at time of implantation,
- •Systemic or topical medication, other than prescribed study medications that may confound the outcome or increase the risk to the subject,
- •Allergy to anesthetics or other postoperative medications required in this study,
- •Subject who is pregnant, plans to become pregnant, or is lactating during the course of the study, or has another condition associated with the fluctuation of hormones that could lead to refractive changes,
- •Subjects who present any emotional, physiologic, or anatomical condition which may preclude study participation.
研究组 & 干预措施
Study population
Experimental
EDOF ICL implanted into both eyes of eligible subjects.
干预措施: EDOF ICL (Device)
结局指标
主要结局
Number of Eyes With Monocular Uncorrected Near Visual Acuity of 20/40 or Better at 40 cm 6 Months After Implantation
时间窗: 6 months
Number of Eyes with Monocular Uncorrected Near Visual Acuity of 20/40 or better at 40 cm six months after implantation
次要结局
- Change From Baseline in Monocular Uncorrected Intermediate Visual Acuity at 80 cm 3 Months Post Implantation(Baseline and 3 months)
- Change From Baseline in Monocular Uncorrected Intermediate Visual Acuity at 80 cm 1 Month Post Implantation(Baseline and 1 month)
- Change From Baseline in Monocular Uncorrected Near Visual Acuity at 40 cm 1 Month Post Implantation(Baseline and 1 month)
- Change From Baseline in Monocular Distance Corrected Intermediate Visual Acuity at 80 cm 1 Month Post Implantation(Baseline and 1 month)
- Change From Baseline in Monocular Distance Corrected Near Visual Acuity at 40 cm 3 Months Post Implantation(Baseline and 3 months)
- Change From Baseline in Binocular Uncorrected Near Visual Acuity at 40 cm 6 Months Post Implantation(Baseline and 6 months)
- Change From Baseline in Binocular Uncorrected Near Visual Acuity at 40 cm 1 Month Post Implantation(Baseline and 1 month)
- Percentage of Implanted Eyes Achieving Monocular Uncorrected Near Visual Acuity of 20/40 or Better at 40 cm 1 Month After Implantation(1 month)
- Percentage of Implanted Eyes Achieving Monocular Uncorrected Near Visual Acuity of 20/40 or Better at 40 cm 3 Months After Implantation(3 months)
- Change From Baseline in Monocular Uncorrected Near Visual Acuity at 40 cm 3 Months Post Implantation(Baseline and 3 months)
- Change From Baseline in Monocular Uncorrected Near Visual Acuity at 40 cm 6 Months Post Implantation(Baseline and 6 months)
- Change From Baseline in Monocular Distance Corrected Intermediate Visual Acuity at 80 cm 3 Months Post Implantation(Baseline and 3 months)
- Change From Baseline in Monocular Distance Corrected Intermediate Visual Acuity at 80 cm 6 Months Post Implantation(Baseline and 6 months)
- Change From Baseline in Monocular Distance Corrected Near Visual Acuity at 40 cm 1 Month Post Implantation(Baseline and 1 month)
- Change From Baseline in Monocular Distance Corrected Near Visual Acuity at 40 cm 6 Months Post Implantation(Baseline and 6 months)
- Change From Baseline in Binocular Uncorrected Near Visual Acuity at 40 cm 3 Months Post Implantation(Baseline and 3 months)
- Change From Baseline in Monocular Uncorrected Intermediate Visual Acuity at 80 cm 6 Months Post Implantation(Baseline and 6 months)
研究者
研究点 (6)
Loading locations...
相似试验
Unknown
不适用
The OPTICA Study - The Optimised Computed Tomography Pulmonary Angiography (CTPA) in Pregnancy, Quality and Safety StudyPregnancy RelatedVenous ThromboembolismPulmonary EmbolismNCT04179487University College Dublin464
已完成
不适用
Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous EyesLens OpacitiesCataractPresbyopiaNCT04699266Beaver-Visitec International, Inc.23
已完成
不适用
Clinical Evaluation of Multifocal Intraocular Lens: OPTIVIS.TMCataract SenileLenses, IntraocularNCT03512626Parc de Salut Mar32
已完成
不适用
Clinical Investigation of the AcrySof IQ Vivity Extended Vision Intraocular Lens (IOL)AphakiaNCT04098367Alcon Research222
Unknown
不适用
To Evaluate IOL Position, Clinical Outcome of PanOptix in High Myopic Cataract PatientsCataractHigh MyopiaNCT05042856Wenzhou Medical University20